Portfolio Committee on Health David Crow Managing Director BAT South Africa.

Slides:



Advertisements
Similar presentations
Impact of JUSFTA on affordability and availability of medicines from perspective of local generic manufacturers Towards equitable and affordable medicine.
Advertisements

Division: EIDD WTO TBT Workshop on Good Regulatory Practice March 2008 Focus on Transparency and Consultation.
Quitting smoking is always the best option, however, some smokers are not yet ready or willing to quit and continue to inflict harm on themselves and the.
Reducing the toll of smoking-related disease and death: The case for tobacco harm reduction The rationale for establishing low-toxicity smokeless nicotine.
Presentation to the Joint Committees’ Meeting on Second 2010 FIFA World Cup South Africa Special Measures Bill (proposed section 76 B ) and 2010.
Menthol and Tobacco Regulation
 2011 Johns Hopkins Bloomberg School of Public Health Regulation of Tobacco Products Mitch Zeller, JD Pinney Associates.
MDQuit Best Practices Conference Kathleen S. Hoke, J.D. January 23, 2013.
Towards a Freedom of Information Law in Qatar Fahad bin Mohammed Al Attiya Executive Chairman, Qatar National Food Security Programme.
Canadian E-cigarette Regulation Presentation by Reza B.
Kenneth E. Warner University of Michigan University of Iowa November 15, 2002 Technology, Policy, and the Future of Nicotine Addiction.
Current challenges in tobacco prevention – do new products pose threats or opportunities? Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden.
GENETICALLY MODIFIED ORGANISM PRESENTATION 13 September 2013 By Department of Trade and Industry.
Regulations Relating to Foodstuffs for Infants and Young Children (Foodstuffs, Cosmetics and Disinfectants Act, 1972) Briefing to the Portfolio Committee.
 2007 Johns Hopkins Bloomberg School of Public Health Section B A Look Ahead: Summary of Main Findings.
Evidence-based/Best Practices Tobacco Control Hadii Mamudu, PhD, MPA COPH-China Institute November 17, 2011.
Oral Submission on the Tobacco Products Control Amendment Bill, 2008 to the Parliamentary Portfolio Committee on Health JT International South Africa (Pty)
The WHO Global Alcohol Strategy: What Role for Industry? Jim Finkle FIVS President Istanbul, Turkey 14 June 2012.
Ryan Liptak, Ryan Merk, Mary Frances Meier Microeconomics.
Presentation in support of The Tobacco Products Amendment Bill 2006 Joel Perry and Dr Carl Albrecht CANSA.
Le rôle de la réduction de dommages dans la lutte antitabac The role of harm reduction in tobacco control Lars M. Ramström Institute for Tobacco Studies.
Department of Medicine. The Harm Reduction Debate Current context of the debate - Snus enthusiasts vs. pessimists Switching from cigarettes to snus alone.
Smoking cessation aided by low-toxicity smokeless tobacco can save many lives Lars M. Ramström Institute for Tobacco Studies Täby, Sweden UKNSCC 2014 Thursday.
1 TOBACCO PRODUCTS CONTROL AMENDMENT BILL 2006, SOUTH AFRICA Presentation by the Department of Health to the Portfolio Committee on Health 7 June 2006.
EU perspective on occupational health and safety - role and place of unions Károly György Kiev, December December Károly György, MSZOSZ.
Page 1 Implementation of the WTO Decision on TRIPS and Public Health Government of Canada August 2004.
THE BIOSAFETY BILL, 2007 JACARANDA HOTEL, 26 TH JULY 2007.
Summary of the Submission on the Employment Relations (Flexible Working Hours) Amendment Bill by the bill’s author, Sue Kedgley, MP.
2007 PRESENTATION TO THE PARLIAMENTARY PORTFOLIO COMMITTEE ON SCIENCE AND TECHNOLOGY ON THE ASTRONOMY GEOGRAPHIC ADVANTAGE BILL [B ] 31 July 2007.
PRESENTATION TO THE NCOP ON THE CONVENTION ON INTERNATIONAL INTERESTS IN MOBILE EQUIPMENT BILL, MARCH 2007.
The Tobacco Institute of Southern Africa ILLICIT TRADE IN CIGARETTES 25 March 2015 COMESA BUSINESS COUNCIL 25 March 2015 COMESA BUSINESS COUNCIL.
Cutting tobacco’s death toll − an overview of different options Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 5th Annual Conference.
The Role of Harm Reduction in Tobacco control – An Update of Pros and Cons Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 53rd International.
IPASA presentation to Portfolio Committee on Health 31 October 2014 Abeda Williams.
 2007 Johns Hopkins Bloomberg School of Public Health Section B Tobacco Control Experiences in Developing Countries.
The Heart and Stroke Foundation South Africa Presented by: Zulfa Abrahams (Dietician)
TPP Impending Interference with States’ Obligations to the WHO FCTC Dr. Zarihah Zain Malaysian Women’s Action for Tobacco Control & Health.
Quitting smoking is always the best option however, some smokers are not yet ready or willing to quit and continue to inflict harm on themselves and the.
Medical Schemes Amendment Bill, 2002 Department of Health Briefing to Portfolio Committee on Health 3 September 2002.
Policies for helping smokers who cannot quit: a prerequisite for maximum prevention of tobacco induced diseases Lars M. Ramström Institute for Tobacco.
1 VOLUNTARY MERCURY CELL PHASE OUT PROGRAMME OF INDIA Dr.Y.R.SINGH Executive Director ALKALI MANUFACTURERS’ ASSOCIATION OF INDIA MERCURY TECHNICAL BRIEFING.
PUBLIC ADMINISTRATION MANAGEMENT BILL PRESENTATION TO THE PORTFOLIO COMMITTEE ON PUBLIC SERVICE AND ADMINISTRATION 27 FEBRUARY 2014.
PRESENTATION TO THE PORTFOLIO COMMITTEE ON TRADE AND INDUSTRY COMPANIES BILL [B ] 13 August 2008 By: Bernard Peter Agulhas – Acting Chief Executive.
5/18/09 TMAAAPHP Tobacco Control Task ForceSlide 1 Tobacco Harm Reduction  Buyer/Hagan/Burr v. Kennedy/Waxman  A Public Health Perspective  Live Video.
1 SUBMISSION TO THE PARLIAMENTARY PORTFOLIO COMMITTEE ON POLICE “THE PRIVATE SECURITY INDUSTRY REGULATION AMENDMENT BILL, 2012” PRESENTED BY: C LOUW 1.
INSURANCE LAWS AMENDMENT BILL Finance Portfolio Committee Parliament 30 May 2008 Council for Medical Schemes Alex van den Heever (Technical Advisor to.
DEPARTMENT OF HEALTH TOBACCO PRODUCTS CONTROL AMENDMENT BILL 2008 (B7-2008) FEEDBACK TO PORTFOLIO COMMITTEE 13 MAY 2008.
Tobacco Control Legislation in South Africa Ms Vimla Moodley Director: Health Promotion National Department of Health Commemoration of World Environmental.
Addressing the Federal Legalization of Cannabis Briefing to Standing Committee on Priorities and Planning June 7, 2017.
13 September 2013 By Department of Trade and Industry
Comments on the Marine Spatial Planning Bill
TOBACCO PRODUCTS CONTROL AMENDMENT BILL 2006, SOUTH AFRICA
PRESENTATION TO PORTFOLIO COMMITTEE ON TRANSPORT 22 SEPTEMBER 2015
Addressing the Federal Legalization of Cannabis Briefing to Standing Committee on Priorities and Planning June 7, 2017.
EU tobacco and nicotine regulations - general aspects
Contents Introduction Strategic Priorities
Presentation to the Portfolio Committee on Health 31 January 2007
TOBACCO PRODUCTS CONTROL AMENDMENT BILL 2006, SOUTH AFRICA
EIUG Energy Intensive Users Group Comments on the Energy Bill
PRESENTATION BY THE LOA TO THE PORTFOLIO COMMITTEE ON FINANCE
SUBMISSION BY BUSA TO THE PORTFOLIO COMMITTEE ON TRADE AND INDUSTRY REGARDING THE SPECIAL ECONOMIC ZONES BILL 21 MAY 2013 Presenters Ms Nomaxabiso Majokweni.
SUBMISSION BY BUSA TO THE PARLIAMENTARY PORTFOLIO COMMITTEE ON TRADE AND INDUSTRY REGARDING THE BROAD BASED-BLACK ECONOMIC EMPOWERMENT AMENDMENT BILL MARCH.
Minor Uses A North American Perspective
Stefan Berggren Marine and Water director, Sweden
IMPLEMENTATION OF THE SOUTH AFRICAN LANGUAGE PRACTITIONERS COUNCIL ACT, 2014 (Act No. 8 of 2014) PRESENTED TO THE SELECT COMMITTEE ON EDUCATION & RECREATION.
Stefan Berggren Marine and Water director, Sweden
AERODROME CERTIFICATION COURSE
TRANSPORT LAWS & RELATED MATTERS AMENDMENT BILL, 2012 PORTFOLIO COMMITTEE ON TRANSPORT 20 November 2012.
Global Burden of Tobacco
A Look Ahead: Summary of Main Findings
Presentation transcript:

Portfolio Committee on Health David Crow Managing Director BAT South Africa

Who we are  BAT is the largest tobacco manufacturer in SA  We sell 70% of legal tobacco products bought in SA  Our company employs 2300 people  We purchase 60% of the South African tobacco crop  We have invested more than R127 million in corporate social investment activities in the last four years  Our parent company, the second largest tobacco company in the world, is 30% South African-owned

Our approach to tobacco regulation  We support balanced regulation of tobacco products  South Africa has the opportunity to lead the world in regulating tobacco harm reduction  The requirements of the WHO FCTC are substantially met by the Act as it stands  We are committed to working with all stakeholders to reduce the negative health impact of tobacco use

Issues raised in our submission  Reducing the negative health impact of tobacco use  Definitions  Brand Element  Organised Activity  Tobacco Product  Standards for Manufacturing and Export of tobacco products  The Minister’s Wide Regulatory Powers  Ignition Propensity of Cigarettes

Issues raised in our submission  Reducing the health impact of tobacco use  Definitions  Brand Element  Organised Activity  Tobacco Product  Standards for Manufacturing and Export of tobacco products  The Minister’s Wide Regulatory Power  Ignition Propensity of Cigarettes  Reducing the health impact of tobacco use  The Minister’s wide regulatory powers  Ignition propensity of cigarettes  Organised activity

What is Harm Reduction?  Harm reduction is an established public health priority  Harm reduction examples include  free condom distribution  low fat content in foods  sugar free products  low alcohol products  safety glass and air bags in vehicles  Parliament must seek pragmatic rather than abolitionist solutions  Parliament now has the opportunity to lay a meaningful foundation for regulated tobacco harm reduction

Reducing the negative health impact of tobacco  There are many facets to potential tobacco harm reduction  lower tar and nicotine intake  reducing the number of smokers  reducing the amount people smoke  eliminating underage consumption  limiting public exposure to environmental tobacco smoke (ETS)  alternative methods of nicotine ingestion such as smokeless tobacco products like Swedish style snus  Some of these are open to debate

Two approaches to harm reduction  Abolition  Abstinence – ‘quit or die’  Harm Reduction  Accepts that people will continue to take risks, but by reducing the scale/nature of the risks, and tries to mitigate the harm that might otherwise result

Reducing the health impact of tobacco  Quote from the ACSH released on 10 October 2006: “Smokeless tobacco use is a much-ignored means of reducing the overwhelming health risks of smoking point out that the public health establishment has misled smokers about the benefits and risks of substituting smokeless tobacco for cigarettes.”  “Stop scaremongering, snus is saving many lives in Sweden” Rutqvist and Ramstrom, Dagens Medicin 2006

Reducing the health impact of tobacco  The following bodies have advocated snus as a harm reduction alternative:  The Royal College of Physicians  Institute for Tobacco Studies, Sweden  American Council on Science and Health  WHO’s International Agency for Research on Cancer  Action on Smoking and Health  University of Louisville

Reducing harm – a solution 1.Regulators have an obligation to acknowledge the concept of tobacco harm reduction as a viable and necessary alternative to abstinence 2.Harm reduction products should be regulated, but separately from conventional tobacco products 3.For this reason the existing definition of “tobacco product” in the current Act needs to be retained, thereby excluding harm reduction products such as Swedish style snus

Reducing harm – a solution 4. The Department of Health needs to urgently engage constructively with all stakeholders, including the tobacco industry to:  understand the dynamics of tobacco harm reduction  establish a solid foundation for regulating tobacco harm reduction  implement a holistic tobacco harm reduction framework

Organised activity  The definition of “organised activity” has been amended to include a “tobacco manufacturer’s company name”.  This will prohibit manufacturers from the normal business practice of hosting corporate stakeholder events which are not associated with consumers or aimed at the promotion of its tobacco brands

The Minister’s wide regulatory powers  The Bill provides wide powers for the Minister of Health to regulate tobacco products and their consumption  Section 6(1)(e) of the existing Act gives the Minister power to change: ‘any other matter required or permitted to be prescribed in terms of a provision of this Act to achieve the objects of the Act’  If the proposed amendments are passed, material changes to the control of tobacco products could be made without Parliamentary involvement

The Minister’s wide regulatory powers  For example the Minister could regulate:  the disclosure of confidential marketing expenditure and research data  the standards for manufacturing of tobacco products  the standards for other sovereign countries that receive tobacco exports from South Africa  the ignition propensity of cigarettes  The role of Parliament is being undermined  The Constitutional Court recently highlighted the imperative of proper public participation  The separation of legislative and executive powers needs to be protected

Ignition propensity of cigarettes  A very new concept in the industry  American Standard adopted by only 2 American states and Canada  Rejected by New Zealand regulatory authorities due to the lack of an appropriate testing standard  Minimal global research conducted on unintended negative consequences  Possibly being promoted for commercial advantage by a US tobacco manufacturer who hold certain patent rights  Dr Johnson-Hill is available for technical information

Summary  There are less harmful tobacco products available for smokers  South Africa has the ability to lead the world in implementing a substantially new way to regulate tobacco  Parliament now has the opportunity to lay a meaningful foundation for regulated tobacco harm reduction  Harm reduction is an established public health priority

Summary  Parliament needs to ensure that its power remains intact and is not usurped by the Minister  Organised activity needs revision  The Department of Health should be cautioned against the impact of unintended negative consequences of over- regulating the tobacco industry  Over-regulation can exacerbate the scourge of illicit trade as generally only legitimate manufacturers can afford to comply with many of the regulations  Over-regulation can exclude the Parliamentary process  Ignition propensity of ‘fire safe’ cigarettes needs in depth research

Thank you

Supplementary information

Illicit trade in tobacco products in SA  The trade in illicit tobacco products in South Africa has reached alarming proportions  In certain areas of Gauteng upwards of 4 out of 10 cigarettes consumed are illegal  Consumers buys 10 million illegal cigarettes everyday  Government is losing over R1,2 billion rand per annum to illicit trade in tobacco products

Prevalence of smoking and snus use in Sweden Data Statistics Sweden and Public Health Institute 2004.

Swedish style snus  Swedish style snus is made of moist, ground tobacco that is pasteurised and packed in small sachets  The sachets are placed between the gum and upper lip  Snus products are not burnt or smoked hence the absence of environmental tobacco smoke  Snus is not associated with lung disease

A ‘safer’ alternative?

Harm Reduction References  The Royal College of Physicians -  American Council on Science and Health –  Tobacco-Harm Reduction Research, University of Louisville, Kentucky USA -  University of Alberta, Canada -  Action on Smoking and Health -